Each year there are about 20 million new cases of sexually transmitted infections (STIs) in the United States. More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in 2022. Adolescents, young adults, and men who have sex…
Attend the 2022 APHL Annual Conference, a hybrid event for the public health laboratory (PHL) community. Come meet with the Seegene Technologies team (BOOTH# 500) to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets with high accuracy…
Join us for NILA's first "live" meeting in over 2 years! Come meet with the Seegene Technologies team to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets with high accuracy for infectious diseases, respiratory infections, and…
Throughout the COVID-19 pandemic, identifying individuals who have been infected with SARS-CoV-2 in a reliable and timely manner has been a crucial strategy in controlling the spread of the disease. Over the course of the last two years, several at-home…
Published on: PR Newswire Dr. Hansen to provide clinical input to the product development process; strengthen strategic partnerships with U.S. networks SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM),…
2022 ASM Clinical Virology Symposium We are looking forward to meeting you at ASM CVS! The Seegene Technologies team will be set up at Booth 622, so come by to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets…
Published on Korea Biomedical Review Seegene, a multiplex molecular diagnostics company, said that it has developed a diagnostic reagent that can identify the Covid-19 infection in 30 minutes. Seegene's new product, Allplex SARS-CoV-2 fast MDx Assay, has obtained the Conformity…
After the global spikes in positive Omicron variant cases in December 2021 and January 2022, February saw a dip in the number of COVID-19 cases and deaths worldwide. In addition to this, several US states have lifted mask mandates. Large…
Although the “original” BA.1 subvariant of Omicron is the dominant form of the SARS-CoV-2 variant worldwide, a subvariant, BA.2 is now spreading rapidly in Asia and in parts of Europe and is reported to be the dominant form of SARS-CoV-2…
In 2020, the news broke that the Pfizer and Moderna SARS-CoV-2 vaccines had reached historic milestones. This began the conversation about a roll-out plan and how our lives would be impacted moving forward. At that point in time, many schools…
Image by Arek Socha from Pixabay The recently reported Omicron variant of SARS-CoV-2 has a 69-70del mutation in the S-gene (which codes for the spike protein). This implies that the S-gene is not detected on PCR tests. The World Health…
Image by Alexandra_Koch from Pixabay On Friday, November 26, the Omicron variant of SARS-CoV-2, the agent behind COVID-19 was classified as a variant of concern by the World Health Organization (WHO) after reports of its detection and genetic sequence were released…
Published on: PR Newswire The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube Seegene will support countries in need of diagnostics to help slow Omicron's spread Seegene Inc. (KQ…